A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by the NHS. The National Institute for Health and Care Excellence (NICE) has ...

An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...

For more than 30 years, Yale endocrinologist Kevan Herold has been researching treatments for Type 1 diabetes (T1D). For just as long, he’s been the principal investigator for multiple clinical trials ...

Learn how aggressive neuroendocrine carcinoma disrupts daily life—and why rapid treatment, strong caregiver support, and navigation resources matter. In this episode, ‘Current Treatments and Biomarker ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way ...

In a recent update, the National Comprehensive Cancer Network (NCCN) recommended capivasertib combined with fulvestrant for hormone receptor–positive and HER2-negative locally advanced or metastatic ...

Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 was ...